Skye Bioscience (SKYE) Earnings Analysis

Skye Bioscience (SKYE) next reports earnings on 2026-08-06, consensus EPS -0.29 USD. Last quarter (2026-05-11) it missed with EPS -0.32 USD vs -0.29 USD est (-10.3%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -0.44.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SKYE next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-0.29 USD
Revenue estimaten/a

SKYE earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-11-0.32 USD-0.29 USD-10.3%Miss
2026-03-10-0.36 USD-0.2971 USD-21.2%Miss
2025-11-10-0.32 USD-0.33 USD+3%Beat
2025-05-08-0.28 USD-0.31 USD+9.7%Beat
2025-03-20-0.24 USD-0.28 USD+14.3%Beat
2024-08-09-0.2 USD-0.2 USD0%Beat

Beat rate: 4/6 (67%) over reported quarters with consensus data.

SKYE valuation and analyst view

Trailing P/E-0.44
Trailing EPS-1.44478 USD
Price / book2.82
Dividend yield0.00%
Market cap0.02B
Analyst consensusBuy (5 buy / 0 hold / 0 sell)
Avg price target2 USD

Related research pages

Frequently asked questions

When is Skye Bioscience (SKYE)'s next earnings date?

Skye Bioscience is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.29 USD.

Did SKYE beat earnings last quarter?

In its 2026-05-11 report, SKYE posted EPS of -0.32 USD versus a -0.29 USD estimate — a miss of 10.3%.

What is SKYE's earnings track record?

Over the last 6 reported quarters with consensus data, SKYE beat estimates 4 times (67%).

What is SKYE's current P/E ratio and EPS?

SKYE trades at a trailing P/E of -0.44 on trailing EPS of -1.4447766986425525 USD.

What do analysts rate SKYE?

Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 2 USD.